Insulet Corp Files 8-K for Material Definitive Agreement

Ticker: PODD · Form: 8-K · Filed: 2024-05-20T00:00:00.000Z

Sentiment: neutral

Topics: material-agreement, disclosure

TL;DR

Insulet signed a big deal, details TBD.

AI Summary

On May 15, 2024, Insulet Corporation entered into a Material Definitive Agreement. The filing does not provide specific details about the agreement or any associated dollar amounts. The company is incorporated in Delaware and headquartered in Acton, Massachusetts.

Why It Matters

This filing indicates a significant new contract or partnership for Insulet Corporation, which could impact its future business operations and financial performance.

Risk Assessment

Risk Level: medium — The filing is a standard disclosure of a material agreement, but the lack of specific details about the agreement's terms and financial implications introduces some uncertainty.

Key Players & Entities

FAQ

What is the nature of the Material Definitive Agreement entered into by Insulet Corporation?

The filing does not specify the nature of the Material Definitive Agreement, only that one was entered into on May 15, 2024.

Are there any financial terms or dollar amounts associated with this agreement disclosed in the filing?

No, the filing does not disclose any specific financial terms or dollar amounts related to the Material Definitive Agreement.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on May 15, 2024.

Where is Insulet Corporation's principal executive office located?

Insulet Corporation's principal executive office is located at 100 Nagog Park, Acton, Massachusetts 01720.

What is the SEC file number for Insulet Corporation?

The SEC file number for Insulet Corporation is 001-33462.

From the Filing

0001145197-24-000024.txt : 20240520 0001145197-24-000024.hdr.sgml : 20240520 20240520160159 ACCESSION NUMBER: 0001145197-24-000024 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240515 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240520 DATE AS OF CHANGE: 20240520 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INSULET CORP CENTRAL INDEX KEY: 0001145197 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 043523891 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33462 FILM NUMBER: 24964304 BUSINESS ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 BUSINESS PHONE: 978-600-7000 MAIL ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 8-K 1 podd-20240515.htm 8-K podd-20240515 0001145197 FALSE 0001145197 2024-05-15 2024-05-15 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K   CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported):  May 15, 2024   INSULET CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-33462 04-3523891 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 100 Nagog Park Acton Massachusetts 01720 (Address of Principal Executive Offices, including Zip Code) Registrant’s telephone number, including area code: (978) 600-7000 Not Applicable (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter) Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐ Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.001 Par Value Per Share PODD The NASDAQ Stock Market, LLC Item 1.01 Entry into a Material Definitive Agreement. On May 15, 2024, Insulet Corporation (the “ Company ”) and NXP USA, Inc. (“ NXP ”) entered into an Addendum (the “ Addendum ”) to the Purchase Agreement, dated as of October 12, 2017, between the Company and NXP (the “ Original Agreement ”). Pursuant to the Addendum, the term of the Original Agreement is extended, the definition of a force majeure event is clarified, and certain terms and conditions related to pricing and other matters are amended. The foregoing description of the Addendum is not intended to be complete and is qualified in its entirety by reference to the full text of the Addendum, filed as Exhibit 10.1 hereto and incorporated by reference herein. Item 9.01 Financial Statements and Exhibits. (d) Exhibits.

View on Read The Filing